These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17678967)

  • 1. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.
    Van Eldik LJ; Thompson WL; Ralay Ranaivo H; Behanna HA; Martin Watterson D
    Int Rev Neurobiol; 2007; 82():277-96. PubMed ID: 17678967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
    Munoz L; Ralay Ranaivo H; Roy SM; Hu W; Craft JM; McNamara LK; Chico LW; Van Eldik LJ; Watterson DM
    J Neuroinflammation; 2007 Sep; 4():21. PubMed ID: 17784957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
    Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia and mast cells: two tracks on the road to neuroinflammation.
    Skaper SD; Giusti P; Facci L
    FASEB J; 2012 Aug; 26(8):3103-17. PubMed ID: 22516295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders.
    Jha MK; Lee WH; Suk K
    Biochem Pharmacol; 2016 Mar; 103():1-16. PubMed ID: 26556658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
    McGeer PL; McGeer EG
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S1-6. PubMed ID: 9769023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glia and their cytokines in progression of neurodegeneration.
    Mrak RE; Griffin WS
    Neurobiol Aging; 2005 Mar; 26(3):349-54. PubMed ID: 15639313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation.
    Baby N; Patnala R; Ling EA; Dheen ST
    Curr Med Chem; 2014; 21(37):4215-26. PubMed ID: 25039775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between neuroinflammation and neurodegenerative diseases].
    Qiu AW; Liu Z; Guo J; Peng YP
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):353-8. PubMed ID: 22242402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of formyl peptide receptors (FPR) in abnormal inflammation responses involved in neurodegenerative diseases.
    Mollica A; Stefanucci A; Costante R; Pinnen F
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(1):20-36. PubMed ID: 22934745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glia: an important target for anti-inflammatory and antidepressant activity.
    Hashioka S; Miyaoka T; Wake R; Furuya M; Horiguchi J
    Curr Drug Targets; 2013 Oct; 14(11):1322-8. PubMed ID: 24020976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches to the treatment of neuroinflammatory diseases.
    Hays SJ
    Curr Pharm Des; 1998 Aug; 4(4):335-48. PubMed ID: 10197047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways.
    Zeng KW; Wang S; Dong X; Jiang Y; Tu PF
    Phytomedicine; 2014 Feb; 21(3):298-306. PubMed ID: 24055519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effects of m-chlorophenylpiperazine in brain glia cells.
    Hwang J; Zheng LT; Ock J; Lee MG; Suk K
    Int Immunopharmacol; 2008 Dec; 8(12):1686-94. PubMed ID: 18771755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular phenotypes as inflammatory mediators in Parkinson's disease: Interventional targets and role of natural products.
    Jiang X; Ganesan P; Rengarajan T; Choi DK; Arulselvan P
    Biomed Pharmacother; 2018 Oct; 106():1052-1062. PubMed ID: 30119171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target.
    Choi DK; Koppula S; Choi M; Suk K
    Expert Opin Ther Pat; 2010 Nov; 20(11):1531-46. PubMed ID: 20939683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution-Associated Molecular Patterns (RAMPs) as Endogenous Regulators of Glia Functions in Neuroinflammatory Disease.
    Wenzel TJ; Kwong E; Bajwa E; Klegeris A
    CNS Neurol Disord Drug Targets; 2020; 19(7):483-494. PubMed ID: 32614758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases.
    Fakhoury M
    Neurodegener Dis; 2015; 15(2):63-9. PubMed ID: 25591815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.